Optimization of human interferon gamma production in Escherichia coli by response surface methodology

Biotechnology and Bioprocess Engineering

Volumn 13, Issue 1, 2008, Pages 7-13

  Balderas Hernández, Victor E ^a   Paz Maldonado, Luz M T ^a   Rivero, Emilio Medina ^a   Barba de la Rosa, Ana P ^a   Ordoñez Acevedo, Leandro G ^a   Rodríguez, Antonio De León ^a  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

Author keywords

Escherichia coli BL21 SI; Minimum medium; Synthetic gene; Therapeutic protein

Indexed keywords

RECOMBINANT GAMMA INTERFERON; SODIUM CHLORIDE; SYNTHETIC DNA;

ARTICLE; BACTERIAL GENE; BIOMASS PRODUCTION; BIOTECHNOLOGICAL PROCEDURES; BIOTECHNOLOGICAL PRODUCTION; BOX BEHNKEN DESIGN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; INTERMETHOD COMPARISON; NONHUMAN; PROCESS DESIGN; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RESPONSE SURFACE METHOD; TEMPERATURE;

ESCHERICHIA COLI;

EID: 40549087966     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12257-007-0126-5     Document Type: Article

References (38)

1. Khalilzadeh, R., S. A. Shojaosadati, A. Bahrami, and N. Maghsoudi (2003) Over-expression of recombinant human interferon-gamma in high cell density fermentation of Escherichia coli. Biotechnol. Lett. 25: 1989-1992.
2. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume (2004) Interferon-γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
3. Whiteside, T. L. (2005) IFN-γ: Detection and prevention of release. Curr. Med. Chem. Anti Inflamm. Anti Allergy Agents. 4: 121-131.
4. Makrides, S. C. (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60: 512-538.
5. Swartz, J. R. (2001) Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12: 195-201.
6. Schmidt, F. R. (2004) Recombinant expression systems in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65: 363-372.
7. Studier, F. W. (2005) Protein production by autoinduction in high density shaking cultures. Protein Expr. Purif. 41: 207-234.
8. Hannig, G. and S. C. Makrides (1998) Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol. 16: 54-60.
9. Jana, S. and J. K. Deb (2005) Strategies for efficient production of heterologous proteins in Escherichia coli. Appl. Microbiol. Biotechnol. 67: 289-298.
10. Wu, G., N. Bashir-Bello, and S. J. Freeland (2006) The synthetic gene designer: A flexible web platform to explore sequence manipulation for heterologous expression. Protein Expr. Purif. 47: 441-445.
11. Nikerel, I. E., E. Toksoy, B. Kirdar, and R. Yildirim (2005) Optimizing medium composition for TaqI endonuclease production by recombinant Escherichia coli cells using response surface methodology. Process Biochem. 40: 1633-1639.
12. Zheng, S., K. Friehs, N. He, X. Deng, Q. Li, Z. He, C. Xu, and Y. Lu (2007) Optimization of medium of components for plasmid production by recombinant E. coli DH5α pUK21CMVβ1.2. Biotechnol. Bioprocess Eng. 12: 213-221.
13. Bird, P. I., S. C. Pak, D. M. Worrall, and S. P. Bottomley (2004) Production of recombinant serpins in Escherichia coli. Methods 32: 169-176.
14. Ma, X., W. Zheng, T. Wang, D. Wei, and Y. Ma (2006) Optimization and high-level expression of a functional GST-tagged rHLT-B in Escherichia coli and GM1 binding ability of purified rHLT-B. J. Microbiol. 44: 293-300.
15. Baş, D. and I. H. Boyacy (2007) Modeling and optimization I: Usability of response surface methodology. J. Food Eng. 78: 836-845.
16. Donahue, R. A., Jr. and R. L. Bebee (1999) BL21-SI competent cells for protein expression in E. coli. Focus 21: 49-51.
17. Box, G. E. P. and D. W. Behnken (1960) Some new three level designs for the study of quantitative variables. Technometrics 2: 455-475.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
19. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
20. Wada, K., Y. Wada, F. Ishibashi, T. Gojobori, and T. Ikemura (1992) Codon usage tabulated from the Gen-Bank genetic sequence data. Nucleic Acids Res. 20: S2111-S2118.
21. Kane, J. F. (1995) Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol. 6: 494-500.
22. Lithwick, G. and H. Margalit (2003) Hierarchy of sequence-dependent features associated with prokaryotic translation. Genome Res. 13: 2665-2673.
23. Gustafsson, C., S. Govindarajan, and J. Minshull (2004) Codon bias and heterologous protein expression. Trends Biotechnol. 22: 346-353.
24. Deng, T. (1997) Bacterial expression and purification of biologically active mouse c-Fos proteins by selective codon optimization. FEBS Lett. 409: 269-272.
25. Hale, R. S. and G. Thompson (1998) Codon optimization of the gene encoding a domain from human Type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli. Protein Expr. Purif. 12: 185-188.
26. Feng, L., W. W. Chan, S. L. Roderick, and D. E. Cohen (2000) High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain. Biochemistry 39: 15399-15409.
27. Li, A., Z. Kato, H. Ohnishi, K. Hashimoto, E. Matsukuma, K. Omoya, Y. Yamamoto, and N. Kondo (2003) Optimized gene synthesis and high expression of human interleukin-18. Protein Expr. Purif. 32: 110-118.
28. Frelin, L., G. Ahlen, M. Alheim, O. Weiland, C. Barnfield, P. Liljestrom, and M. Sallberg (2004) Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther. 11: 522-533.
29. Paz Maldonado, L. M. T., V. E. B. Hernandez, E. M. Rivero, A. P. Barba de ka Rosa, J. L. Pores, L. G. O. Acevedo, and A. De León (2007) Optimization of culture conditions for a synthetic gene expression in Escherichia coli using response surface methodology: The case of human interferon beta. Biomol. Eng. 24: 217-222.
30. Niemitalo, O., A. Neubauer, U. Liebal, J. Myllyharju, A. H. Juffer, and P. Neubauer (2005) Modelling of translation of human protein disulfide isomerase in Escherichia coli - A case study of gene optimization. J. Biotechnol. 120: 11-24.
31. Bhandari, P. and J. Gowrishankar (1997) An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer. J. Bacteriol. 179: 4403-4406.
32. Ling, H. (2002) Physiology of Escherichia coli in batch and fed-batch cultures with special emphasis on amino acid and glucose metabolism. Doctoral thesis. Department of Biotechnology, Royal Institute of Technology, Stockholm, Sweden (http://media.lib.kth.se:8080/ dissengrefhit.asp?dissnr=3334).
33. Ignatova, Z., A. Mahsunah, M. Georgieva, and V. Kasche (2003) Improvement of posttranslational bottlenecks in the production of penicillin amidase in recombinant Escherichia coli strains. Appl. Environ. Microbiol. 69: 1237-1245.
34. Neubauer, P., K. Hofmann, O. Holst, B. Mattiansson, and P. Kruschke (1992) Maximizing the expression of a recombinant gene in Escherichia coli by manipulation of induction time using lactose as inducer. Appl. Microbiol. Biotechnol. 36: 739-744.
35. Donovan, R. S., C. W. Robinson, and B. R. Glick (1996) Optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J. Ind. Microbiol. 16: 145-154.
36. De Léon, A., H. Jiménez-Islas, M. González-Cuevas, and A. P. Barba de la Rosa (2004) Analysis of the expression of the Trichoderma harzianum ech42 gene in two isogenic clones of Escherichia coli by surface response methodology. Process Biochem. 39: 2173-2178.
37. Zhang, Z., K. T. Tong, M. Belew, T. Pettersson, and J. C. Janson (1992) Production, purification and characterization of recombinant human interferon-γ. J. Chromatogr. 604: 143-155.
38. Dobrovolsky, V. N., O. V. Lagutin, T. V. Vinogradova, I. S. Frolova, V. P. Kuznetsov, and O. A. Larionov (1993) Human gamma-interferon expression in the mammary gland of transgenic mice. FEBS Lett. 319: 181-184.